Home/Filings/4/0001104659-25-019171
4//SEC Filing

EBSWORTH DAVID R 4

Accession 0001104659-25-019171

CIK 0001657312other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:30 PM ET

Size

20.4 KB

Accession

0001104659-25-019171

Insider Transaction Report

Form 4
Period: 2025-02-26
Transactions
  • Gift

    Ordinary Shares

    2025-02-2664,0001,336,003 total
  • Exercise/Conversion

    Ordinary Shares

    2025-02-26$0.78/sh+64,000$49,6001,004,003 total
  • Exercise/Conversion

    Ordinary Shares

    2025-02-26$0.50/sh+200,000$100,7601,204,003 total
  • Exercise/Conversion

    Ordinary Shares

    2025-02-26$1.93/sh+100,000$193,3801,400,003 total
  • Exercise/Conversion

    Share Option (Right to Exercise)

    2025-02-26200,0000 total
    Exercise: $0.50Exp: 2032-04-27Ordinary Shares (200,000 underlying)
  • Exercise/Conversion

    Share Option (Right to Exercise)

    2025-02-2696,0000 total
    Exercise: $2.67Exp: 2033-04-27Ordinary Shares (96,000 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-02-26$2.67/sh+96,000$256,3201,300,003 total
  • Exercise/Conversion

    Share Option (Right to Exercise)

    2025-02-2664,0000 total
    Exercise: $0.78Exp: 2031-08-08Ordinary Shares (64,000 underlying)
  • Exercise/Conversion

    Share Option (Right to Exercise)

    2025-02-26100,000140,000 total
    Exercise: $1.93Exp: 2034-04-28Ordinary Shares (100,000 underlying)
Footnotes (5)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]Consists of (i) 1,336,000 Ordinary Shares represented by 167,000 ADSs and (ii) 3 Ordinary Shares.
  • [F3]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F4]The option is fully vested.
  • [F5]The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025.

Issuer

Verona Pharma plc

CIK 0001657312

Entity typeother

Related Parties

1
  • filerCIK 0001207107

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:30 PM ET
Size
20.4 KB